Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

The Leibniz-Forschungsinstitut für Molekulare Pharmakologie is a research institute in the Leibniz Association, focussing on proteins as basic structures of cellular organisms. It is one of the large number of research institutions based in Berlin. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Germany, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

60%


Total
Publications

2.1K


Total Open
Publications

1.3K


Total
Citations

86K


Open Access
Percentage

60%


Total
Publications

2.1K


Total Open
Publications

1.3K


Total
Citations

86K

Wikipedia

Website

download

Breakdown

18% 34% 6% 42%

Publisher Open

18%

Both

34%

Other Platform Open

6%

Closed

42%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

47%OA Journal

OA Journal 47%

468

Hybrid 33%

328

No Guarantees 20%

202

Other Platform Open

Domain 65%

521

Institution 53%

426

Other Internet 20%

162

Public 5%

36

Preprint 0%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
520
DOI
Other Internet
139
ZB MED - Informationszentrum Lebenswissenschaften
Institution
117
Universitätsbibliothek der Freien Universität Berlin - Refubium
Institution
70
Max Planck Society - MPG.PuRe
Institution
53
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
40
Europe PMC
Domain
33
DANS - Data Archiving and Networked Services
Institution
31
Unknown Repository
Other Internet
27
Figshare
Public
27
1 / 13

Data updated 18 August 2025

Share

Share

Share